Amphastar Pharmaceuticals, Inc. (AMPH) Stock Price, Quote & AI Analysis

Live AMPH stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Amphastar Pharmaceuticals, Inc..

TradeVae provides AI-driven analysis and real-time market intelligence for Amphastar Pharmaceuticals, Inc. (AMPH), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

AMPH
Amphastar Pharmaceuticals, Inc.
real-time
$0.00 +0.00 (+0.00%)
Open
26.360000
High
27.160000
Low
26.340000
Volume
39,345
VWAP
-
Market Cap
$1,217,273,089.26
52W Range
$20.39 - $36.35
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 25, 2026 Q4
After Hours
EPS Estimate: $0.9436
Revenue Estimate: $194,289,600.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Amphastar Pharmaceuticals, Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Amphastar Pharmaceuticals, Inc. Overview

Company information

Company Overview

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Company Details
Market Cap
$1.24B
Shares Outstanding
45,952,200
Weighted Shares Outstanding
45,952,174
CEO
Yong Feng Zhang
Address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
Employees
2,028
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Amphastar Pharmaceuticals, Inc. Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...